Revolution Medicines (RVMD) Other Non Operating Income (2024 - 2026)
Revolution Medicines (RVMD) posted Other Non Operating Income of -$6000.0 for Q2 2026, down 105.13% on a QoQ basis from $117000.0 in Q1 2026, and up 81.25% year-over-year from -$3310.3 in Q2 2025.
Powered by 
Analysis
Revolution Medicines (RVMD) Other Non Operating Income (2024 - 2026) Analysis & Trends
Revolution Medicines has reported Other Non Operating Income for 3 years, with the latest figure at -$6000.0 in Q2 2026.
- On a quarterly basis, Other Non Operating Income rose 81.25% year-over-year to -$6000.0 in Q2 2026; TTM through Jun 2026 was $58.3 million, a 22656.25% increase from a year earlier, with the FY2025 full-year figure at $58.1 million, changed N/A from the prior year.
- Other Non Operating Income was -$6000.0 for Q2 2026 at Revolution Medicines, down from $117000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $58.1 million in Q4 2025, with the low at -$2.8 million in Q1 2024.
- Average Other Non Operating Income over 3 years is $7.0 million, with a median of $5000.0 recorded in 2024.
- The sharpest annual moves came in 2025 and 2026: Other Non Operating Income plunged 300.0% in 2025, then surged 1270.0% in 2026.
- Over 3 years, Other Non Operating Income stood at $282000.0 in 2024, then jumped by 20518.79% to $58.1 million in 2025, then tumbled by 100.01% to -$6000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$6000.0 (Q2 2026), $117000.0 (Q1 2026), and $58.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn |
| 10 | Revolution Medicines | 40.86 Bn | 40.86 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6,000.00 |
| Mar 31, 2026 | 117,000.00 |
| Dec 31, 2025 | 58.15 Mn |
| Jun 30, 2025 | -32,000.00 |
| Mar 31, 2025 | -10,000.00 |
| Sep 30, 2024 | 282,000.00 |
| Jun 30, 2024 | 16,000.00 |
| Mar 31, 2024 | -2.81 Mn |
API Access
Revolution Medicines Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();